Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Internal fixation surgery did not significantly improve functional outcomes in patients with closed, displaced humeral shaft fractures compared with nonoperative functional bracing, the FISH* trial has shown.
Women with rheumatoid arthritis (RA) have a reduced risk of breast cancer; similarly, women with breast cancer have a reduced risk of RA, reveals a Swedish study. Moreover, adjuvant antihormonal therapy for breast cancer prevention does not appear to increase the risk of RA.
Vascular pathology appears to be associated with the risk of hand and knee osteoarthritis (OA), with a potential causal relationship for knee OA, suggest the results of a systematic review.
Individually calibrated biomechanical footwear therapy may be effective in reducing knee pain and physical function in individuals with symptomatic knee osteoarthritis (OA), according to the results of the BIOTOK* trial.
Loss of cartilage thickness affects knee pain by a small degree, and this association is partly mediated by worsening synovitis, according to a study.
Treatment with lenabasum is safe and helps improve outcomes in patients with diffuse cutaneous systemic sclerosis, according to the results of a phase II study.
Annual infusions of zoledronic acid did not significantly cut pain and cartilage volume loss in patients with symptomatic knee osteoarthritis (OA) and bone marrow lesions, the ZAP2* trial has shown.
Special Reports
With the objective of establishing a Malaysian consensus on the use of topical NSAIDs in the management of musculoskeletal pain, this meeting brought together experts from various backgrounds, ie, rheumatology, pharmacy, orthopaedics and general medicine. At the meeting, Dr Mary Suma Cardosa delivered a talk on the pathophysiology and effective management of pain, while the lecture by Dr Yeap Swan Sim focused on the management of musculoskeletal and soft-tissue pain. This article presents excerpts from the expert meeting and features the consensus statements agreed during the meeting.
Conference Reports
Privacy and transparency are among the core points to consider when utilizing big data in rheumatic and musculoskeletal disorders (RMDs), according to the first EULAR-endorsed recommendations for use of big datasets in research.
A combination of tocilizumab and methotrexate reduced disease activity at 2 years compared with methotrexate plus prednisone in patients with early rheumatoid arthritis (RA), an effect not demonstrated with tocilizumab monotherapy.
Patients with painful hand osteoarthritis can finally get relief from pain with low-dose prednisolone, suggests a study presented at EULAR 2019.
Occupational exposure to inorganic dust, particularly asbestos, silica, and coal, was associated with an increased risk of developing gout, according to a study presented at EULAR 2019.
Being overweight may have an impact on disease severity in psoriatic arthritis, according to a study presented at EULAR 2019.
The selective Janus kinase 1 inhibitor upadacitinib demonstrated sustained efficacy and safety beyond 12 weeks in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate response or were refractory to disease-modifying antirheumatic drugs (DMARDs), according to the interim results of the ongoing extension phases of SELECT-NEXT* and SELECT-BEYOND** presented at EULAR 2019.
Both inflammatory bowel disease (IBD) and type 1 diabetes (T1D) are highly prevalent among patients who eventually develop rheumatoid arthritis (RA), indicating that these two conditions are potential risk factors for RA, according to a study presented at EULAR 2019.
